Prediction of PD-1 immunotherapy (IO) response for KRAS mutated non-small cell lung cancer (NSCLC) based on co-mutations using a computational biological model. Annals of oncology : official journal of the European Society for Medical Oncology Wakelee, H., Aredo, J., Vali, S., Singh, N. K., Vasista, S. V., Mitra, U., Abbasi, T., Padda, S. K. 2018; 29 Suppl 8: viii510–viii511

View details for DOI 10.1093/annonc/mdy292.036

View details for PubMedID 32137320